Lexicon Pharmaceuticals, Inc. - Common Stock (NQ:LXRX)

1.780 +0.170 (+10.56%)

Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lexicon Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Crude Oil Moves Higher; Apple Shares Slide After Q4 Results ↗

November 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 01, 2024

Via Benzinga

Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results ↗

November 01, 2024

Via Benzinga

Dow Jumps 400 Points; US Adds 12,000 Jobs In October ↗

November 01, 2024

Via Benzinga

Topics Stocks

Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

November 01, 2024

Via Benzinga

Beyond The Numbers: 7 Analysts Discuss Lexicon Pharmaceuticals Stock ↗

September 27, 2024

Via Benzinga

FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes ↗

November 01, 2024

Lexicon Pharmaceuticals' sotagliflozin, under review as an adjunct to insulin for type 1 diabetes and CKD, faced an FDA panel vote against approval, with mixed expert support.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 01, 2024

Via Benzinga

Deep Dive Into Lexicon Pharmaceuticals Stock: Analyst Perspectives (9 Ratings) ↗

October 23, 2024

Via Benzinga

Peeling Back The Layers: Exploring Lexicon Pharmaceuticals Through Analyst Insights ↗

October 17, 2024

Via Benzinga

The Analyst Verdict: Lexicon Pharmaceuticals In The Eyes Of 8 Experts ↗

September 03, 2024

Via Benzinga

Analyst Scoreboard: 6 Ratings For Lexicon Pharmaceuticals ↗

August 13, 2024

Via Benzinga

5 Analysts Have This To Say About Lexicon Pharmaceuticals ↗

August 02, 2024

Via Benzinga

Lexicon Pharmaceuticals: Q4 Earnings Insights ↗

March 11, 2024

Via Benzinga

Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket ↗

August 02, 2024

Via Benzinga

Intel Reports Weak Results, Joins Amazon, Opendoor Technologies And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

August 02, 2024

Via Benzinga

Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 17, 2024

Via Benzinga

Aaron's, Nvidia, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday ↗

June 17, 2024

Via Benzinga

Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day ↗

May 13, 2024

The company is hoping to take on Bristol Myers Squibb's Camzyos, a treatment for obstructive HCM.

Via Investor's Business Daily

LXRX Stock Earnings: Lexicon Pharmaceuticals Meets EPS, Misses Revenue for Q1 2024 ↗

May 02, 2024

LXRX stock results show that Lexicon Pharmaceuticals met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday ↗

April 22, 2024

Via Benzinga

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 27, 2024

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.

Via Benzinga

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday ↗

March 27, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Via Benzinga

Topics Stocks

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 12, 2024

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.

Via Benzinga

Dow Turns Higher; GDS Holdings Shares Climb ↗

March 11, 2024

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&P 500 also...

Via Benzinga

Topics Stocks

Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump ↗

March 11, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded down 0.16% to 38,662.09 while the NASDAQ fell 0.26% to 16,043.75. The S&P 500...

Via Benzinga

Topics Stocks

Top 4 Health Care Stocks You May Want To Dump In February ↗

February 15, 2024

As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 11, 2024

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...

Via Benzinga

3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts ↗

January 31, 2024

If a trio of Wall Street analysts is correct, three lesser-known stocks could skyrocket in the new year.

Via The Motley Fool

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.